Genomic Valley Biotech Ltd.
BSE: 539206
₹27.30
₹0.00 (0.00%)As on 08-Jun-2026IST
Market cap
₹8 Cr
Revenue (TTM)
₹0 Cr
P/E Ratio
278
P/B Ratio
2.1
Div. Yield
0 %
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
₹0 Cr
-
ROE
9.6 %
-
ROCE
11.9 %
-
Industry P/E
277.96
-
EV/EBITDA
188.9
-
Debt to Equity
0
-
Book Value
₹--
-
EPS
₹0.1
-
Face value
10
-
Shares outstanding
3,054,500
10 Years Aggregate
CFO
₹-1.48 Cr
EBITDA
₹1.35 Cr
Net Profit
₹0.60 Cr
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Genomic Biotech
| 10.5 | 21.3 | -5.9 | -41.9 | 9.7 | -- | -- |
|
BSE Healthcare*
| 8.7 | 1.4 | 8.4 | 9.2 | 24.9 | 13.5 | 12.2 |
|
Company
|
2025
|
2024
|
|---|---|---|
|
Genomic Biotech
| -69.8 | 103.4 |
|
BSE Small Cap
| -6.6 | 29.0 |
|
BSE Healthcare
| -3.3 | 43.1 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Genomic Biotech
|
27.3 | 8.3 | 0.3 | 0.0 | 15.7 | 0.8 | 278 | 2.1 |
| 187.9 | 2,956.9 | 2,931.9 | 97.5 | 7.7 | 1.5 | 30.3 | 0.4 | |
| 523.4 | 12,631.7 | 3,510.5 | 401.1 | 14.0 | 13.9 | 31.5 | 4.0 | |
| 70.1 | 249.2 | 128.4 | -10.4 | -9.4 | -10.4 | -- | 2.7 | |
| 252.8 | 11,446.9 | 2,950.9 | 420.1 | 17.0 | 14.6 | 27.4 | 3.8 | |
| 1,229.7 | 26,076.4 | 2,192.5 | 348.9 | 21.2 | 14.9 | 74.7 | 10.5 | |
| 4,713.3 | 10,840.6 | 935.0 | 257.9 | 34.3 | 78.9 | 42 | 24.0 | |
| 29.6 | 437.9 | 54.2 | 10.9 | -4.1 | 13.9 | 40.4 | 14.1 | |
| 24.5 | 54.1 | 53.3 | -1.7 | 20.3 | -14.9 | -- | 0.6 |
Shareholding Pattern
View DetailsNews & Analysis
All NewsNo Review & Analysis are available.
About Genomic Biotech
Wholesale of agricultural raw materials and live animals
-
Incorporated
1994
-
Chairman
--
-
Managing Director
Yogesh Agrawal
-
Headquarters
Jhajjar Dist, Haryana
-
Website
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
Annual Reports
FAQs for Genomic Biotech
What is the current share price of Genomic Valley Biotech Ltd Today?
The share price of Genomic Valley Biotech Ltd is ₹27.30 (BSE) as of 08-Jun-2026 IST. Genomic Valley Biotech Ltd has given a return of 9.66% in the last 3 years.
What is the current PB & PE ratio of Genomic Valley Biotech Ltd?
The P/E ratio of Genomic Valley Biotech Ltd is 277.96 times as on 08-Jun-2026, a 0 premium to its peers’ median range of 277.96 times.
The P/B ratio of Genomic Valley Biotech Ltd is 2.12 times as on 08-Jun-2026, a 0 premium to its peers’ median range of 2.12 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
50.26
|
4.59
|
|
2024
|
698.34
|
2.99
|
|
2023
|
0.00
|
0.00
|
|
2022
|
0.00
|
0.00
|
|
2021
|
0.00
|
0.00
|
What is the 52 Week High and Low of Genomic Valley Biotech Ltd?
The 52-week high and low of Genomic Valley Biotech Ltd are Rs 54.27 and Rs 20.10 as of 10-Jun-2026.
What is the market cap of Genomic Valley Biotech Ltd?
Genomic Valley Biotech Ltd has a market capitalisation of ₹ 8 Cr as on 08-Jun-2026. As per SEBI classification, it is a Small Cap company.
Should I invest in Genomic Valley Biotech Ltd?
Before investing in Genomic Valley Biotech Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.